Valuation: CellSeed Inc.

Market Cap 4.1B 25.93M 23.26M 21.51M 19.48M 36.39M 2.47B 36.83M 257M 102M 1.29B 97.3M 95.25M P/E 2020
-4.47x
P/E 2021 -3.46x
Enterprise Value 3.33B 21.06M 18.89M 17.47M 15.82M 29.55M 2.01B 29.91M 209M 83.18M 1.05B 79.02M 77.35M EV / Sales 2020
12.4x
EV / Sales 2021 15.5x
Free-Float
96.44%
Yield 2020 *
-
Yield 2021 -
1 day+2.65%
1 week-0.51%
Current month-13.39%
1 month-14.54%
3 months-10.19%
6 months-30.47%
Current year-25.10%
1 week 175
Extreme 175
202
1 month 175
Extreme 175
232
Current year 175
Extreme 175
416
1 year 175
Extreme 175
444
3 years 175
Extreme 175
1,160
5 years 122
Extreme 122
1,160
10 years 122
Extreme 122
2,020
Manager TitleAgeSince
President 73 01/06/2014
Chief Administrative Officer 50 01/05/2025
Corporate Officer/Principal 70 01/10/2017
Director TitleAgeSince
Director/Board Member 73 01/03/2014
Director/Board Member 75 01/03/2017
Director/Board Member 72 01/03/2023
Change 5-day change 1-year change 3-year change Capi.($)
+2.65%-0.51%-56.11%-39.75% 47.33M
+0.91%+1.85%+57.82%+128.79% 1,143B
+0.94%+5.24%+45.13%+84.51% 647B
-0.03%+0.67%+26.00%+102.06% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-0.78%-6.18%+61.58%+36.95% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.79%+2.77%+54.22%+71.16% 242B
+0.16%+3.54%+34.89%+104.46% 197B
Average +0.51%+0.45%+30.99%+63.11% 402.76B
Weighted average by Cap. +0.46%+0.71%+44.70%+87.25%

Financials

2020 2021
Net sales 199M 1.26M 1.13M 1.04M 945K 1.77M 120M 1.79M 12.47M 4.97M 62.68M 4.72M 4.62M 161M 1.02M 913K 844K 764K 1.43M 96.92M 1.45M 10.09M 4.02M 50.71M 3.82M 3.74M
Net income -783M -4.95M -4.44M -4.11M -3.72M -6.95M -471M -7.03M -49.08M -19.55M -247M -18.57M -18.18M -914M -5.78M -5.18M -4.79M -4.34M -8.11M -550M -8.21M -57.29M -22.82M -288M -21.68M -21.22M
Net Debt -1.3B -8.22M -7.37M -6.82M -6.17M -11.53M -783M -11.67M -81.49M -32.46M -409M -30.83M -30.18M -771M -4.87M -4.37M -4.04M -3.66M -6.84M -464M -6.92M -48.33M -19.25M -243M -18.29M -17.9M
Logo CellSeed Inc.
CellSeed Inc. is mainly engaged in the regenerative medical business. The Company operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.
Employees
44
Date Price Change Volume
28/10/26 ¥194.00 +2.65% 213,300
27/10/26 ¥189.00 -0.53% 119,000
26/10/26 ¥190.00 +0.53% 126,100
23/10/26 ¥189.00 -1.56% 372,200
22/10/26 ¥192.00 -4.00% 225,400
  1. Stock Market
  2. Stocks
  3. 7776 Stock